Sinopharm's COVID-19 vaccine remained active against South Africa variant, effect reduced: lab study
BEIJING (Reuters) - Two COVID-19 vaccines from Chinese companies including Sinopharm triggered immunity against a highly transmissible coronavirus variant first found in South Africa, but their effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results